DelveInsight's Macrophage Activation Syndrome Market Insights report includes a comprehensive understanding of current treatment practices, macrophage activation syndrome emerging drugs, market share ...

When a drug is injected directly into a tumour, macrophages already present in the body absorb the drug and begin producing ...

Researchers identify altered expression of genes that worsens periodontitis among smokers, and a new target molecule ...

KAIST researchers have developed a way to reprogram immune cells already inside tumors into cancer-killing machines. A drug ...

KAIST researchers unveil a new cancer therapy that reprograms immune cells inside tumours, eliminating lab-based CAR ...

Multiple sclerosis (MS) is a chronic neurological disease characterized by nerve damage and consequent impairments in vision, ...

KAIST researchers have developed an innovative treatment that transforms immune cells within tumours into cancer-fighting ...

The market was valued at $110m in 2024. The macrophage activation syndrome sector in the six major markets (6MM) is expected ...

The immune system remains seriously out-of-whack—in an inflammatory state of overactivation and impaired ...

Piezoelectric nanoparticles deployed inside immune cells and stimulated remotely by ultrasound can trigger the body's disease ...

Researchers at the Korea Advanced Institute of Science and Technology (KAIST) have developed a groundbreaking cancer treatment strategy that reprogrammes immune cells already present inside tumours, ...

A study on rabbits dosed with viper venom suggests that botulinum toxin may alleviate some effects of snakebite, possibly by ...